All In Biotech

Drugs by condition

Drugs approved for atopic dermatitis (eczema)

Brand-name prescription drugs and biologics whose FDA label lists atopic dermatitis (eczema) as an approved use. Matched on the label phrases: "atopic dermatitis".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

26

Still marketed, NDA or BLA

Drug classes

10

Novel drugs

13

New molecular entities and new biologics

In development

40+

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for atopic dermatitis (eczema).

  • Adquey (Difamilast) · Acrotech Biopharma NovelFeb 12, 2026
  • Ebglyss (Lebrikizumab-Lbkz) · Eli Lilly and CO NovelSep 13, 2024
  • Nemluvio (Nemolizumab-Ilto) · Galderma Labs Lp NovelBreakthrough therapyPriority reviewAug 12, 2024
  • Rinvoq Lq (Upadacitinib) · Abbvie OrphanApr 26, 2024
  • Zoryve (Roflumilast) · Arcutis Jul 29, 2022

All approved drugs for atopic dermatitis (eczema), by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 147 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Corticosteroid (4)

  • Medrol Methylprednisolone · Pfizer · 1957
  • Derma-Smoothe/Fs Fluocinolone Acetonide · Hill Dermac · 1988
  • Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
  • Cortef Hydrocortisone · Pharmacia and Upjohn · 1952

Phosphodiesterase 4 Inhibitor (3)

  • Adquey Difamilast · Acrotech Biopharma · 2026
  • Eucrisa Crisaborole · Anacor Pharms INC · 2016
  • Zoryve Roflumilast · Arcutis · 2022

Janus Kinase Inhibitor (3)

  • Cibinqo Abrocitinib · Pfizer · 2022
  • Rinvoq Upadacitinib · Abbvie · 2019
  • Rinvoq Lq Upadacitinib · Abbvie · 2024

Interleukin-13 Antagonist (2)

  • Ebglyss Lebrikizumab-Lbkz · Eli Lilly and CO · 2024
  • Adbry Tralokinumab · Leo Pharma As · 2021

Interleukin-31 Receptor alpha Antagonist (1)

  • Nemluvio Nemolizumab-Ilto · Galderma Labs Lp · 2024

Aryl Hydrocarbon Receptor Agonist (1)

  • Vtama Tapinarof · Organon LLC · 2022

Interleukin-4 Receptor alpha Antagonist (1)

  • Dupixent Dupilumab · Regeneron Pharmaceuticals · 2017

Calcineurin Inhibitor Immunosuppressant (1)

  • Elidel Pimecrolimus · Bausch · 2001

Adrenocorticotropic Hormone (1)

Class not listed in FDA's data (9)

  • Opzelura Ruxolitinib Phosphate · Incyte Corp · 2021
  • Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Protopic Tacrolimus · Leo Pharma As · 2000
  • Zonalon Doxepin Hydrochloride · Mylan · 1994
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
  • Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
  • Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
  • Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955

Drugs in development for atopic dermatitis (eczema)

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • HSK44459Phase 39 trials

    Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • SHR-1819Phase 38 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Seasonal Allergic Rhinitis, Moderate to Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • barzolvolimabCDX-0159Phase 37 trials

    Celldex Therapeutics · Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria

  • MG-K10Humanized Monoclonal AntibodyPhase 36 trials

    Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis

  • SHR-1905Phase 36 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • VC005Phase 35 trials

    Jiangsu vcare pharmaceutical technology co., LTD · Non-segmental Vitiligo, Non-Segmental Vitiligo, Atopic Dermatitis

  • ICP-332Phase 34 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis

  • Jaktinib HydrochloridePhase 34 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Atopic Dermatitis, Ankylosing Spondylitis

  • Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)

  • RezpegaldesleukinNKTR-358, REZPEGPhase 34 trials

    Nektar Therapeutics · Moderate-to-Severe Atopic Dermatitis, Moderate to Severe Atopic Dermatitis, Alopecia Areata

  • LNK01001Phase 33 trials

    Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis

  • QY201Phase 33 trials

    E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · Adult Subjects With Non-Segmental Vitiligo, Atopic Dermatitis (AD), Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)

  • RocatinlimabAMG 451Phase 33 trials

    Amgen · Atopic Dermatitis

  • TQH2722Phase 33 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis

More on atopic dermatitis (eczema): recruiting trials · published research

Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Chronic hives (urticaria) · Alopecia areata

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.